Samsara Bio Capital, LLC Lyra Therapeutics, Inc. Transaction History
Samsara Bio Capital, LLC
- $326 Million
- Q4 2024
A detailed history of Samsara Bio Capital, LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 1,965,689 shares of LYRA stock, worth $393,137. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,965,689
Previous 2,780,261
29.3%
Holding current value
$393,137
Previous $722,000
42.94%
% of portfolio
0.13%
Previous 0.42%
Shares
4 transactions
Others Institutions Holding LYRA
# of Institutions
54Shares Held
26.2MCall Options Held
21KPut Options Held
0-
Perceptive Advisors LLC New York, NY12.8MShares$2.55 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$565,9950.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.79MShares$357,4840.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$211,6290.04% of portfolio
-
Geode Capital Management, LLC Boston, MA886KShares$177,1930.0% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $6.37M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...